首页>
外国专利>
Treatment of familial exudative vitreoretinopathy through S1PR2 inhibition
Treatment of familial exudative vitreoretinopathy through S1PR2 inhibition
展开▼
机译:通过抑制S1PR2治疗家族性渗出性玻璃体视网膜病变
展开▼
页面导航
摘要
著录项
相似文献
摘要
Methods and compositions are provided for the treatment of familial exudative vitreoretinopathy (FEVR) and retinopathy of prematurity (ROP) through the administration of a therapeutically effective amount of a Sphingosine-1-phosphate receptor type 2 (S1PR2) inhibitor.
展开▼